(AHN) – The U.S. Food and Drug Administration announced Thursday it will recall the 2008 approval given to Genentech for the drug Avastin as advanced breast cancer treatment. The revocation, which is rarely made by the agency, was preceded by a 12-1 vote among members of the FDA advisory committee in July.
Read the original post by Andy